|
Advances in gynaecology in the last 50 years have transformed women’s lives. In particular, research into reproductive hormones has brought enormous benefits to women.
A wide choice of effective and innovative methods for female health
In the reproductive years, the choice to prevent pregnancy through the use of effective contraception is recognised as a basic human right. Hormonal contraceptives are a particularly effective and widely used form of contraception enabling millions throughout the world the opportunity to exercise that right.
After the reproductive years, women enter a different life stage. The increase in life expectancy over the last decades means that women’s health and well being after the menopause has assumed a greater importance than ever before. Today one third of a woman's life is enjoyed in the postmenopausal state and although the transition is natural, the concomitant decline in oestrogen production may have early- and long-term health implications. Fortunately, associated problems can today be managed therapeutically.
Organon and gynaecology
Organon has great heritage and experience in the area of gynaecology. This has resulted in a leading position in contraception. Organon today offers a wide choice of effective and innovative methods. It continues to invest in the development and introduction of new contraceptives and is one of only three companies substantially involved in research and development in this area.
Organon is also a pioneer in the field of menopausal treatments providing innovative products for over eight decades. As a leader in this area, the company remains fully committed to the research and development of menopausal products optimising patient safety, patient care and therapeutic cost-effectiveness.
Organon also holds a leading position in fertility. Organon is committed to reproductive health and has been bringing quality products to the field of infertility for about 75 years. |
|
|
